Fig. 3 | Scientific Reports

Fig. 3

From: DEFB4A/hBD2, a non-invasive serum biomarker for detection of ulcerative colitis

Fig. 3

(a) Pathway analysis with deregulated genes in active UC patients vs. IBS-control group using KEGG pathway analysis. Validation of genes by qRT-PCR analysis from top two altered pathways (b) Immune response pathways (IL6, TLR4, STAT3 and IFN-γ) and (c) Anti-microbial immune response pathways (REG3A, S100A8, hBD2). *, ** and ns mean p < 0.05, 0.01 and not significant respectively.

Back to article page